SAPA-NE 2026 Biotech Startup Roadshow
Sat, Nov 07
|Arnold & Porter Kaye Scholer LLP
SAPA-NE invites you to an afternoon with some of New England's most promising biotech startups. Founders will present their science and plans to a panel of venture investors and industry leaders, and then take live questions from the judges.
Event Time
Nov 07, 2026, 12:30 PM – 5:30 PM EST
Arnold & Porter Kaye Scholer LLP, 500 Boylston St 20th floor, Boston, MA 02116, USA
About the Event
Founders pitch. Investors and industry leaders judge. Boston connects.
Saturday, November 7, 2026 | 12:30 – 5:30 PM ET | In Person Arnold & Porter, 500 Boylston St, 20th Floor, Boston, MA 02116
About This Event
SAPA-NE invites you to an afternoon with some of New England's most promising biotech startups. Founders will present their science and plans to a panel of venture investors and industry leaders, and then take live questions from the judges.
It's a chance to see new drug discovery platforms early, hear how experienced investors evaluate a company, and meet founders, investors and peers from across the Boston biotech community.
Why Attend
See new science early. AI-enabled drug discovery, ALS and neurodegeneration, AI for human physiology, RNA therapeutics, and oral peptides
Learn how investors think. Judges' live Q&A shows what VCs and pharma look for in a startup
Meet the ecosystem. Network with founders, investors, and industry professionals in a small-room setting
Who Should Attend
Founders and aspiring entrepreneurs, investors, business development and corporate strategy professionals, and scientists curious about the startup path.
Presenting Startups
Bin Chen, PhD, Founder, Bronto Therapeutics Transcriptome-based AI-enabled drug discovery
Chengliang Zhang, PhD, Co-founder, Alteron Therapeutics Pharmacological inhibition of TDP-43 activity as a paradigm-shifting therapeutic strategy for ALS, AD and other neurodegenerative disorders
Wei Jin, PhD, CSO, InTimeHealth Building the AI foundation for longitudinal human physiology
Jason Zhang, PhD, Founder, Zipcode Bio Programming Medicine: AI-first RNA therapeutics
John Su, PhD, Founder & CEO, STD Lab Oral cyclic peptide drug development platform
Judges & Mentors
Jerry Fan, CPA: Director of Strategic Finance, Vertex
Claire Jin: Vice President, J.P. Morgan Life Sciences & Healthcare
Leo Qian, PhD: Founder & CEO, stealth startup; Co-founder, Entrada Therapeutics
Gary R. Schall: Partner, Arnold & Porter
Kate Zhang, PhD: Venture Partner, Tailwinds Ventures; former CSO, Hopewell Therapeutics
Registration
Seating is limited to about 25 guests. Registration requires approval.
Please submit a request to attend. We review every request and will email you a confirmation if you are approved and a seat is available. Only confirmed guests can be admitted, and building security will check names at the lobby, so please register with the name on your photo ID.
Questions? Contact us at info@sapa-neweb.org More events: www.sapa-neweb.org/events
Venue courtesy of Arnold & Porter. Thank you for hosting us.
Building Bridges. Advancing Science. Improving Lives.